Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Sara Salvador-MartínBartosz KaczmarczykRebeca ÁlvarezVíctor Manuel Navas-LópezCarmen Gallego-FernándezAna Moreno-ÁlvarezAlfonso Solar-BogaCesar SanchezMar TolinMarta VelascoRosana Muñoz-CodoceoAlejandro Rodriguez-MartinezConcepción A VayoFerrán BossacomaGemma Pujol-MuncunillMaría J FobeloAntonio Millán-JimenezLorena MagallaresEva Martínez-OjinagaInés LoverdosFrancisco J EizaguirreJosé A Blanca-GarcíaSusana Clemente-BautistaRuth García-RomeroVicente Merino-BohórquezRafael González de CaldasEnrique VázquezAna DopazoMaría Sanjurjo-SáezLuis Andrés López-Fernández

Published in: Pharmaceutics (2021)

Expression of the FCGR1A, FCGR1B, and GBP1 genes is a pharmacogenomic biomarker of early response to anti-TNF agents in pediatric IBD.

Keyphrases

rheumatoid arthritis
poor prognosis
genome wide
transcription factor
ulcerative colitis
binding protein
dna methylation
genome wide identification